# XTL Biopharmaceuticals Ltd: Form 6-K, filed Feb 17, 2026

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 21:05 ET
- Period: 2026-02-17
- Accession: 0001213900-26-017282
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000121390026017282/ea0277362-6k_xtlbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000121390026017282/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000121390026017282/ea0277362-6k_xtlbio.htm

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-017282. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.